Intravitreal bevacizumab for age-related macular degeneration with good visual acuity

Japanese Journal of Ophthalmology

Volumn 54, Issue 6, 2010, Pages 565-570

  Takahashi, Maki ^a   Sato, Taku ^a   Kishi, Shoji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

age related macular degeneration; anti VEGF therapy; choroidal neovascularization; good visual acuity; intravitreal bevacizumab injection

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; TREATMENT DURATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; EXUDATES AND TRANSUDATES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 78751638149     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-010-0864-3     Document Type: Article

References (17)

1. Japanese Age-Related Macular Degeneration Trial 2003 Japanese Age-Related Macular Degeneration Trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration Am J Ophthalmol 136 1049 1061 10.1016/S0002-9394(03)00576-2 (Pubitemid 37485771)
2. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1 Arch Ophthalmol 117 1329 1345
3. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy 2001 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2 Arch Ophthalmol 119 198 207
4. Verteporfin In Photodynamic Therapy Study Group. 2001 Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-Verteporfin in Photodynamic Therapy report 2 Am J Ophthalmol 131 541 560 10.1016/S0002-9394(01)00967-9 (Pubitemid 32427660)
5. Treatment of Age-Related Macular Degeneration With Photodynamic TherapyVerteporfin in Photodynamic Therapy Study Groups. 2003 Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP Report No. 1 Am J Ophthalmol 136 407 418 10.1016/S0002-9394(03)00223-X (Pubitemid 37101236)
6. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy 2004 Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3 Am J Ophthalmol 137 683 696 10.1016/j.ajo.2003.11.059 (Pubitemid 38446683)
7. E.S. Gragoudas A.P. Adamis E.T. Cunningham Jr, et al. 2004 VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2805 2816 1:CAS:528:DC%2BD2MXhslyntw%3D%3D 10.1056/NEJMoa042760 15625332 (Pubitemid 40051904)
8. VEGF Inhibition Study in Ocular Neovascularization U. Chakravathy A.P. Adamis E.T. Cunningham Jr, et al. 2006 Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration Ophthalmology 113 1508 1521
9. P.J. Rosenfeld D.M. Brown J.S. Heier, et al. 2006 Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419 1431 1:CAS:528:DC%2BD28XhtVGgtr3M 10.1056/NEJMoa054481 17021318 (Pubitemid 44511557)
10. D.M. Brown P.K. Kaiser M. Michels, et al. 2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 1432 1444 1:CAS:528:DC%2BD28XhtVGgtrrI 10.1056/NEJMoa062655 17021319 (Pubitemid 44511558)
11. Macular Photocoagulation Study Group. 1982 Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial Arch Ophthalmol 100 912 918
12. R.L. Avery D.J. Pieramici M.D. Rabena A.A. Castellarin M.A. Nasir M.J. Giust 2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363 372 10.1016/j.ophtha.2005.11.019 16458968
13. Z.F. Bashshur Z.A. Haddad A. Schakal R.F. Jaafar M. Saav B.N. Noureddin 2008 Intravitreal bevacizumab for treatment of neovascular agerelated macular degeneration: a one-year prospective study Am J Ophthalmol 145 249 256 1:CAS:528:DC%2BD1cXhtV2hsr8%3D 10.1016/j.ajo.2007.09.031 18067876
14. G.A. Lalwani P.J. Rosenfeld A.E. Fung, et al. 2009 A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study Am J Ophthalmol 148 1 3 10.1016/j.ajo.2009.01.024
15. S.J. Bakri M.R. Snyder J.M. Reid J.S. Pulido R.J. Singh 2007 Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology 114 855 859 10.1016/j.ophtha.2007.01.017 17467524 (Pubitemid 46635858)
16. S.J. Bakri M.R. Snyder J.M. Reid J.S. Pulido M.K. Ezzat R.J. Singh 2007 Pharmacokinetics of intravitreal ranibizumab (Lucentis) Ophthalmology 114 2179 2182 10.1016/j.ophtha.2007.09.012 18054637 (Pubitemid 350181137)
17. D.S. Boyer A.N. Antoszyk C.C. Awh R.B. Bhisitkul H. Shapiro N.R. Acharya 2007 Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 246 252 10.1016/j.ophtha. 2006.10.045 17270674 (Pubitemid 46172497)